Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial

作者：Ki Hong Choi, Yong Hwan Park, Jong‐Young Lee, Jin‐Ok Jeong, Chan Joon Kim, Kyeong Ho Yun, Han Cheol Lee, Kiyuk Chang, Mahn‐Won Park, Jang‐Whan Bae, Joon‐Hyung Doh, Byung Ryul Cho, Hee-Yeol Kim, Weon Kim, Ung Kim, Seung‐Woon Rha, Young Joon Hong, Hyun‐Jong Lee, Sung Gyun Ahn, Doo‐Il Kim, Jang Hyun Cho, Sung‐Ho Her, Doo Soo Jeon, Seung Hwan Han, Jin Bae Lee, Cheol Whan Lee, Danbee Kang, Joo Myung Lee, Taek Kyu Park, Jeong Hoon Yang, Soo‐Youn Lee, Seung‐Hyuk Choi, Hyeon‐Cheol Gwon, Young Bin Song, Joo-Yong Hahn · 发表于：The Lancet · 年份：2025 · DOI：10.1016/s0140-6736(25)00449-0 · 被引用次数：97 · 研究领域：Antiplatelet Therapy and Cardiovascular Diseases、Coronary Interventions and Diagnostics、Acute Myocardial Infarction Research